In the original article [1], there was a mistake in Panel E of Figure 2 as published. The original images for the TNFα case were mistakenly used. The corrected Figure 2 appears below.
Figure 2.
Opposing effects of TNFα and TNFα-treated CM on SW1353 CS cells. CN = control, CM = conditioned medium, and C28 = C28/I2 chondrocytes. The single and double asterisks indicate p < 0.05 and 0.01, respectively. (A–C) Increase in MTT-based viability, EdU-based proliferation, and transwell invasion of SW1353 cells in response to 10 ng/mL of TNFα (n = 6). (D) Upregulation of Runx2 and Snail in SW1353 cells by 10 ng/mL of TNFα (n = 6). (E,F) Reduction in EdU-based proliferation of SW1353 cells by TNFα-treated CS cells, MSC, and C28 chondrocyte-derived CMs, respectively (n = 6). The concentration of TNFα was 10 ng/mL.
The authors apologize for any inconvenience caused and state that the results and scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Sun, X.; Li, K.-X.; Figueiredo, M.L.; Lin, C.-C.; Li, B.-Y.; Yokota, H. Generation of the Chondroprotective Proteomes by Activating PI3K and TNFα Signaling. Cancers 2022, 14, 3039. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).